Stay updated on Abemaciclib Combinations in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer updates the site revision from v3.8.0 to v3.8.1; the study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T03:11:22.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The completed Phase 2 study record for abemaciclib, alone or in combination, in previously treated pancreatic ductal adenocarcinoma is available with its study design, eligibility criteria, outcomes, locations, and related research materials.
    Difference
    73%
    Check dated 2026-11-11T02:06:08.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:44:25.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changed from v3.7.1 to v3.7.2, while the study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:39:20.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:49:05.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears, replacing the previous study record content with a standard access-denied screen. As a result, the detailed study information is no longer accessible on this page.
    Difference
    19%
    Check dated 2026-09-23T01:10:34.000Z thumbnail image

Stay in the know with updates to Abemaciclib Combinations in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abemaciclib Combinations in Pancreatic Cancer Clinical Trial page.